Accelerated Intensity-Modulated External Radiotherapy as a New Technical Approach to Treat the Index Quadrant after Conserving Surgery in Early Breast Cancer: A Preliminary Study
Restricted accessResearch articleFirst published online May, 2005
Accelerated Intensity-Modulated External Radiotherapy as a New Technical Approach to Treat the Index Quadrant after Conserving Surgery in Early Breast Cancer: A Preliminary Study
We present a novel technical approach to treat the index quadrant after conserving surgery in patients with early breast cancer and study its clinical feasibility.
Methods and material
Patients selected for the study, after breast conserving surgery with histologically verified breast carcinoma, signed a full informed consent to intensity-modulated external radiotherapy of the partial breast. Treatment was performed with the 6 MV beam from one of the Elekta Precise LINAC units installed in our Department. The prescribed dose was 30 Gy in 5 fractions in 10 days.
Results
Acute toxicity was minimal. No skin changes were noted during treatment or during the first 6 months after radiotherapy treatment.
Conclusions
Accelerated partial breast irradiation using intensity-modulated external radiotherapy is technically feasible. We think the approach will give good results in terms of local control, toxicity and quality of life, at the same time sparing resources for the patient and health care system.
VeronesiU., SaccozziR., Del VecchioM., BanfiA., ClementeC., De LenaM., GallusC., GrecoM., LuiniA., MarubiniE., MuscolinoG., RilkeF., SalvadoriB., ZecchiniA., ZuccaliR.: Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med, 305: 6–11, 1981.
2.
LiljegrenG., HolmbergJ., BerghA., LindgrenA., TabarL., NordgrenH., AdamiH.O.: 10-year result after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol, 17: 2326–2333, 1999.
3.
FisherB., AndersonS., RedmondC.K., WolmarkN., WickerhamD.L., CroninW.M.: Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med, 333: 1456–1461, 1995.
4.
VeronesiU., LuiniA., Del VecchioM, GrecoM., GalimbertiV., MersonM., RilkeF., SacchiniV., SaccozziR., SavioT.: Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med, 328: 1587–1591, 1993.
5.
FisherE.R., AndersonS., RedmondC., FischerB.: Ipsilateral breast tumour recurrence and survival following lumpectomy and irradiation: pathological findings from NSABP protocol B-06. Sem Surg Oncol, 8: 161–166, 1992.
6.
VaidjaJ.S., BaumM.: Clinical and biological implications of the Milan breast conservation trials. Eur J Cancer, 34: 1143–1144, 1998.
7.
VaidjaJ.S., BaumM., TobiasJ.S., D'SouzaD.P., NaiduS.V., MorganS., MetaxasM., HarteK.J., SliskiA.P., ThomsonE.: Targeted inter-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer. Ann Oncol, 12: 1075–1080, 2001.
8.
VaidjaJ.S., VyasJ.J., ChinoyR.F., MerchantN., SharmaO.P., MittraI.: Mulicentricity of breast cancer: whole organ analysis and clinical implications. Br J Cancer, 74: 820–824, 1996.
9.
JonesB., DaleR.G., DeehanC., Hopkins Kiand MorganD.A.L.: The role of biologically effective dose (BED) in clinical oncology, The Royal College of Radiologists. Clin Oncol, 13: 71–81, 2001.
10.
DaleR.G., JonesB.: The assessment of RBE effects using the concept of biologically effective dose. Int J Radiat Oncol Biol Phys, 43: 639–645, 1999.
11.
LeeS.P., LeuM.Y., SmathersJ.B., McBridgeW., ParkerR.G., WithersH.R.: Biologically effective dose distribution based on the linear quadratic model and its clinical relevance. Int J Radiat Oncol Biol Phys, 33: 375–389, 1995.
12.
SmithA., RussoA., MuracaM.G., Del TurcoM.R., CardonaG.: Prognostic factors for lymphedema after primary treatment of breast carcinoma. Cancer, 92: 1783–1787, 2001.
13.
ZucaliR., MersonM., PlacucciM., Di PalmaS., VeronesiU.: Soft-tissue sarcoma of the breast after conservative surgery and irradiation for early breast mammary cancer. Radiother Oncol, 30: 271, 1994.
14.
GelberdR.D., GoldhirschA.: Radiotherapy to the conserved breast: is it avoidable if the cancer is small?J Natl Cancer Inst, 86: 1783–1787, 1994.
15.
PolgarC., FodorJ., MajorT., Takacsi-NagyZ., KaslerM., HammerJ., Van LimbergenE., NemethG.: Radiotherapy confined to the tumour bed following breast conserving surgery: current status, controversies and future projects. Strahlenther Onkol, 178: 597–606, 2002.
16.
WazerD.E., BerleL., GrahanR., ChungM., RothschildJ., GravesT., CadyB., UlinK., RuthazerR., DiPetrilloT.A.: Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys, 53: 889–897, 2002.
17.
PolgarC., SulyokZ., FodorJ., OroszZ., Tacasi-NagyZ., MangelL.C., SomogyiA., KaslerM., NemethG.: T1 breast cancer: five-year results of a phase I-II study and initial findings of a randomised phase III trials. J Surg Oncol, 80: 121–128, 2002.
18.
ViciniF.A., KestinL., ChenP., BenitezP., GoldsteinN.S., MartinezA.: Limited-field radiation therapy in the management of early stage breast cancer. J Natl Cancer Inst, 95: 1205–1210, 2003.
19.
ReitsamerR., PeintingerF., SedlmayerF., KoppM., MenzelC., CimpocaW., GluekS., RabimH., KoppP., DeutschmannH., MerzF., BrandisM., KogelinH.: Intraoperative radiotherapy given as a boost after breast conserving surgery in breast cancer patients. Eur J Cancer, 38: 1607–1610, 2002.
20.
VeronesiU., OrecchiaR., LuiniA., GattiG., IntraM., ZurridaS., IvaldiG., TosiG., CioccaM., TosoniA., De LuciaF.: A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer, 37: 2178–2183, 2001.
21.
RibeiroG.G., MageeB., SwindellR., HarrisM., BanerjeeSS. The Christie Hospital breast conservation trial: an update at eight years from inception. Clin Oncol R Coll Radiol, 5: 278–283, 1993.
22.
HurkmansC.W., ChoB.C.J., DamenE., ZjjpL., MijnheerB.J.: Reduction of cardiac and lung complication probabilities after breast irradiation using conformal radiotherapy with or without intensity modulation. Radiother Oncol, 62: 163–171, 2002.
23.
GagliardiG., LaxI., SoderstromS., GyenesG., RutqvistL.E.: Prediction of excess risk of long-term cardiac mortality after radiotherapy of stage I breast cancer. Radiother Oncol, 46: 63–71, 1998.
24.
HongL., HuntM., ChuiC., SpirouS., FosterK., LeeH., YahalomJ., KutcherG.J., McCormickB.: Intensity-modulated tangential beam irradiation of the intact breast. Int J Radiat Biol Phys, 44: 1155–1164, 1999.
25.
TheB.S., LuH.H., SobremonteS., BellezzaD., ChiuJ.K., CapenterS., DennisS., WooS.Y., ButlerB.: The potential use of intensity modulated radiotherapy (IMRT) in women with pectus excavatum desiring breast-conserving therapy. Breast J, 7: 223–229, 2001.
26.
KestinL.L., SharpeM.B., FrazierR.C., ViciniF.A., YanD., MatterR.C., MartinezA.A., WongJ.W.: Intensity modulation to improve dose uniformity with tangential breast radiotherapy: initial clinical experience. Int J Radiat Biol Phys, 48: 1559–1568, 2000.
27.
ArchambeauJ.O., PeznerR., WassermanT.: Pathophysiology of irradiated skin and breast. Int J Radiat Biol Phys, 31: 1171–1185, 1995.
28.
RoseM., RechtA.: Accelerated partial-breast irradiation (AP-BI): let's give it a good test. Int J Radiat Biol Phys, 57: 1217–1218, 2003.
29.
ViciniF., ArthurD., PolgarC., KuskeR.: Defining the efficacy of accelerated partial breast irradiation: the importance of proper patient selection, optimal quality assurance, and common sense. Int J Radiat Biol Phys, 57: 1210–1213, 2003.
30.
BuchholzT.A.: Partial breast irradiation: is it ready for prime time?Int J Radiat Biol Phys, 57: 1214–1216, 2003.
